The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-fluorophenyl)-2-imino-10-methyl-5-oxo-dipyrido[2,5-c:2',1'-g]pyrimidine-3-carboxylic acid ID: ALA4575723
PubChem CID: 155563901
Max Phase: Preclinical
Molecular Formula: C19H13FN4O3
Molecular Weight: 364.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccn2c(=O)c3cc(C(=O)O)c(=N)n(-c4ccc(F)cc4)c3nc12
Standard InChI: InChI=1S/C19H13FN4O3/c1-10-3-2-8-23-16(10)22-17-14(18(23)25)9-13(19(26)27)15(21)24(17)12-6-4-11(20)5-7-12/h2-9,21H,1H3,(H,26,27)
Standard InChI Key: BGPRDLRUGCIANS-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
12.1671 -16.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1671 -17.1032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8765 -17.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8765 -15.8692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5818 -16.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5828 -17.1032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2912 -17.5128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2892 -15.8702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0021 -16.2801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0024 -17.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7122 -17.5146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4262 -17.1029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4259 -16.2796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7116 -15.8680 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2905 -18.3341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1380 -15.8715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1376 -17.5164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1368 -18.3377 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.7102 -15.0467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8775 -15.0520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8461 -17.1091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4215 -14.6398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4204 -13.8193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7079 -13.4090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9949 -13.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9995 -14.6445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7054 -12.5919 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
5 8 2 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
9 14 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
7 15 2 0
13 16 2 0
12 17 1 0
17 18 2 0
14 19 1 0
4 20 1 0
17 21 1 0
19 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 19 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.34Molecular Weight (Monoisotopic): 364.0972AlogP: 2.26#Rotatable Bonds: 2Polar Surface Area: 100.45Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.61CX Basic pKa: 4.36CX LogP: 1.42CX LogD: -1.03Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.53Np Likeness Score: -1.44
References 1. Dong Z, Wang Z, Guo ZQ, Gong S, Zhang T, Liu J, Luo C, Jiang H, Yang CG.. (2020) Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer., 63 (9): [PMID:32297747 ] [10.1021/acs.jmedchem.0c00161 ]